1. "2017"
Formats
  1. Journal Article (3053)
  2. Meeting Abstract (1581)
  3. Book Section (242)
  4. Conference Paper (35)
  5. Book Whole (12)
  6. Editorial (1)
  7. Review (1)
Groups
  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)

More Groups

People
  1. Sergio Giralt (86)
  2. Jose Baselga (68)
  3. Michael Berger (67)
  4. Monica Morrow (65)
  5. Jedd Wolchok (62)
  6. Martin Tallman (61)

More People

Years
  1. 2017 (4925)
Publications
  1. Journal of Clinical Oncology (349)
  2. Blood (233)
  3. Annals of Oncology (123)
  4. International Journal of Radiation Oncology, Biology, Physics (122)
  5. Modern Pathology (85)
  6. Laboratory Investigation (76)

More Publications

Publishers
  1. Elsevier Inc. (599)
  2. Springer (383)
  3. American Society of Clinical Oncology (378)
  4. Nature Publishing Group (310)
  5. Oxford University Press (280)
  6. American Society of Hematology (246)

More Publishers

Results (4925)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Budget impact analysis of avelumab in patients with metastatic Merkel cell carcinoma in the US
    Meeting Abstract

    Bharmal, M.; D'Angelo, S. P.; Phatak, H.
    Value in Health (2017)

    Fulltext@MSK | Save
  • Important group differences on the Functional Assessment of Cancer Therapy-Kidney Symptom Index disease-related symptoms (FKSI-DRS) in patients with metastatic renal cell carcinoma
    Meeting Abstract

    Cella, D.; Motzer, R.; Rini, B. I.; Cappelleri, J. C.; Ramaswamy, K.; Arondekar, B.; Bushmakin, A. G.
    Value in Health (2017)

    Fulltext@MSK | Save
  • Development of a new patient-reported outcome instrument to evaluate treatments for stretchmarks: The BODY-Q stretchmark scale
    Meeting Abstract

    Klassen, A.; Poulsen, L.; Robson, S.; Sorensen, J. A.; Rose, M.; Juhl, C. B.; Stoving, R. K.; Pusic, A.
    Value in Health (2017)

    Fulltext@MSK | Save
  • Perfusable tissue-engineered model of neuroblastoma for studying drug resistance
    Meeting Abstract

    Villasante, A.; Sakaguchi, K.; Kim, J.; Cheung, N. V.; Nakayama, M.; Parsa, H.; Okano, T.; Shimizu, T.; Vunjak-Novakovic, G.
    Tissue Engineering Part A (2017)

    Fulltext@MSK | Save
  • Malignant transformation of neurocutaneous melanocytosis (NCM) following immunosuppression
    Meeting Abstract

    Schaff, L.; Marghoob, A.; Meyer, R.; Khakoo, Y.
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Skin care products compatible with tumor treating fields
    Meeting Abstract

    Lacouture, M.; Hershkovich, H. S.; Blat, R.; Giladi, M.; Bomzon, Z.; Kirson, E. D.; Weinberg, U.; Palti, Y.
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Value of T2-weighted MR imaging to evaluate drug distribution the brain stem of children
    Meeting Abstract

    Wembacher-Schroeder, E.; Zhou, Z.; Pandit-Tasker, N.; Souweidane, M. M.
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • The development of neurologic immune related adverse events (irAEs) in patients with metastatic solid tumors treated with immune checkpoint inhibitors: A single institution retrospective analysis
    Meeting Abstract

    Malani, R.; Haggiagi, A.; Holder, J.; Shames, Y.; Briggs, S.; Santomasso, B.; Callahan, M.
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Patient perspectives on lumbar puncture
    Meeting Abstract

    Umemura, Y.; Weill, B.; Buthorn, J.; Boire, A.
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • PIK3 mutations are associated with decreased local control in brain metastases treated with radiation
    Meeting Abstract

    Lockney, N.; Wang, D.; Lin, A.; Pei, X.; Chan, T.; Yamada, Y.; Beal, K.; Yang, T. J.
    Neuro-Oncology (2017)

    Fulltext@MSK | Save